{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:58:13Z","timestamp":1787317093280,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier","isbn-type":[{"value":"9780443346491","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apha.2025.01.016","type":"book-chapter","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T10:57:13Z","timestamp":1739703433000},"page":"325-348","source":"Crossref","is-referenced-by-count":6,"title":["Emerging horizons of AI in pharmaceutical research"],"prefix":"10.1016","author":[{"given":"Sourav","family":"Bachhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryasarathi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basudeb","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somnath","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3233\/THC-220284","article-title":"Post-market surveillance of medical devices: A review","volume":"30","author":"Badnjevi\u0107","year":"2022","journal-title":"Technology and Health Care"},{"issue":"10","key":"10.1016\/bs.apha.2025.01.016_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/138620711797537102","article-title":"Virtual high throughput screening in new lead identification","volume":"14","author":"Badrinarayan","year":"2011","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"key":"10.1016\/bs.apha.2025.01.016_bib3","volume":"Vol. 275","author":"Bajorath","year":"2008"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0975-8453.59519","article-title":"Computational approaches for drug design and discovery: An overview","volume":"1","author":"Baldi","year":"2010","journal-title":"Systematic Reviews in Pharmacy"},{"key":"10.1016\/bs.apha.2025.01.016_bib5","doi-asserted-by":"crossref","unstructured":"Beltagy, I., Lo, K., & Cohan, A. (2019). SciBERT: A pretrained language model for scientific text. Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing and the 9th International Joint Conference on Natural Language Processing (EMNLP-IJCNLP). https:\/\/doi.org\/10.18653\/v1\/D19-1371.","DOI":"10.18653\/v1\/D19-1371"},{"issue":"12","key":"10.1016\/bs.apha.2025.01.016_bib6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide Protein Data Bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nature Structural Biology"},{"key":"10.1016\/bs.apha.2025.01.016_bib7","series-title":"The pharmaceutical regulatory process","author":"Berry","year":"2008"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib8","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.1208\/aapsj070351","article-title":"Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications","volume":"7","author":"Bhattaram","year":"2005","journal-title":"The AAPS Journal"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/ph16060891","article-title":"The role of AI in drug discovery: Challenges, opportunities, and strategies","volume":"16","author":"Blanco-Gonz\u00e1lez","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd3385","article-title":"Advances in the preclinical testing of cancer therapeutic hypotheses","volume":"10","author":"Caponigro","year":"2011","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102295","article-title":"The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges","volume":"35","author":"Chakraborty","year":"2024","journal-title":"Molecular Therapy. Nucleic Acids"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.61603\/ceas.v2i1.33","article-title":"Auto-encoding variational bayes","volume":"2","author":"Chen","year":"2024","journal-title":"Cambridge Explorations in Arts and Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib13","doi-asserted-by":"crossref","first-page":"1175S","DOI":"10.1177\/00928615980320S102","article-title":"An overview of the regulatory approval process in drug development","volume":"32","author":"Chow","year":"1998","journal-title":"Drug Information Journal"},{"issue":"9","key":"10.1016\/bs.apha.2025.01.016_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2018.10136","article-title":"Real-world evidence and real-world data for evaluating drug safety and effectiveness","volume":"320","author":"Corrigan-Curay","year":"2018","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.016_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: A next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: A review","volume":"55","author":"Dara","year":"2022","journal-title":"Artificial Intelligence Review"},{"issue":"5","key":"10.1016\/bs.apha.2025.01.016_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.18006\/2022.10(5).932.952","article-title":"Potential of lignocellulolytic biocatalysts of native and proposed genetically engineered microbial cell factories on jute fiber modification and jute waste recycling: A review","volume":"10","author":"Das","year":"2022","journal-title":"Journal of Experimental Biology and Agricultural Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.22207\/JPAM.17.2.19","article-title":"Lignocellulolytic microbial systems and its importance in dye decolourization: A review","volume":"17","author":"Das","year":"2023","journal-title":"Journal of Pure & Applied Microbiology"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1134\/S0026261722601282","article-title":"Concise review on lignocellulolytic microbial consortia for lignocellulosic waste biomass utilization: A way forward?","volume":"92","author":"Das","year":"2023","journal-title":"Microbiology"},{"key":"10.1016\/bs.apha.2025.01.016_bib20","doi-asserted-by":"crossref","DOI":"10.7324\/JABB.2024.193181","article-title":"Molecular characterization of the ligninolytic Sundarban mangrove isolate Stenotrophomonas maltophilia GD1 and its promising applications in the dye and fiber industry","author":"Das","year":"2024","journal-title":"Journal of Applied Biology & Biotechnology"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.22207\/JPAM.17.1.59","article-title":"Isolation and screening of dye degrading lignocellulolytic bacteria from Sundarban Mangrove ecosystem, West Bengal, India","volume":"17","author":"Das","year":"2023","journal-title":"Journal of Pure & Applied Microbiology"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.artmed.2015.03.006","article-title":"Sentiment analysis in medical settings: New opportunities and challenges","volume":"64","author":"Denecke","year":"2015","journal-title":"Artificial Intelligence in Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.22270\/ajprd.v7i6.616","article-title":"The stages of drug discovery and development process","volume":"7","author":"Deore","year":"2019","journal-title":"Asian Journal of Pharmaceutical Research and Development"},{"key":"10.1016\/bs.apha.2025.01.016_bib24","unstructured":"Devlin, J., Chang, M.-W., Lee, K., & Toutanova, K.(2018). BERT: Pre-training of deep bidirectional transformers for language understanding. arXiv [cs.CL]. http:\/\/arxiv.org\/abs\/1810.04805."},{"issue":"22","key":"10.1016\/bs.apha.2025.01.016_bib25","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMp0801872","article-title":"Exploiting a research underclass in phase 1 clinical trials","volume":"358","author":"Elliott","year":"2008","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.016_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: A next-generation drug library and information resource","volume":"23","author":"Ello","year":"2017","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2025.01.016_bib27","series-title":"Methods and applications of statistics in clinical trials","first-page":"65","article-title":"Application of new designs in phase I trials","author":"Garrett-Mayer","year":"2014"},{"key":"10.1016\/bs.apha.2025.01.016_bib28","series-title":"Scaling Up of Microbial Electrochemical Systems","first-page":"217","article-title":"Metabolic engineering and synthetic biology key players for improving efficacy of microbial fuel cell technology","author":"Ghosh","year":"2022"},{"key":"10.1016\/bs.apha.2025.01.016_bib29","series-title":"Genetic and Metabolic Engineering for Improved Biofuel Production from Lignocellulosic Biomass","first-page":"13","article-title":"Genetic and metabolic engineering approaches for improving accessibilities of lignocellulosic biomass toward biofuels generations","author":"Ghosh","year":"2020"},{"key":"10.1016\/bs.apha.2025.01.016_bib30","series-title":"Current Status and Future Scope of Microbial Cellulases","first-page":"171","article-title":"Engineering of microbial cellulases for value-added product generations","author":"Ghosh","year":"2021"},{"key":"10.1016\/bs.apha.2025.01.016_bib31","series-title":"Scaling Up of Microbial Electrochemical Systems","first-page":"239","article-title":"Microbial electrochemical platform: A sustainable workhorse for improving wastewater treatment and desalination","author":"Ghosh","year":"2022"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.016_bib32","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.apha.2025.01.016_bib33","doi-asserted-by":"crossref","DOI":"10.2210\/rcsb_pdb\/goodsell-gallery-050","article-title":"Kinetochore","author":"Goodsell","year":"2024","journal-title":"RCSB Protein Data Bank"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.016_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/bs.apha.2025.01.016_bib35","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.drudis.2022.03.010","article-title":"Advancing automation in high-throughput screening: Modular unguarded systems enable adaptable drug discovery","volume":"27","author":"Hansel","year":"2022","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2310\/JIM.0b013e3181afdb26","article-title":"Understanding FDA regulatory requirements for investigational new drug applications for sponsor-investigators","volume":"57","author":"Holbein","year":"2009","journal-title":"Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2014A free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib38","first-page":"21949","article-title":"Ai-driven drug repurposing: Uncovering hidden potentials of established medications for rare disease treatment","volume":"44","author":"Islam","year":"2024","journal-title":"Library Progress International"},{"issue":"9","key":"10.1016\/bs.apha.2025.01.016_bib39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2021.1909567","article-title":"Artificial intelligence in drug discovery: Recent advances and future perspectives","volume":"16","author":"Jim\u00e9nez-Luna","year":"2021","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.016_bib40","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: Integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.apha.2025.01.016_bib41","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database\u20142009 update","volume":"37","author":"Keshava Prasad","year":"2009","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s12257-020-0049-y","article-title":"Artificial intelligence in drug discovery: A comprehensive review of data-driven and machine learning approaches","volume":"25","author":"Kim","year":"2020","journal-title":"Biotechnology and Bioprocess Engineering: BBE"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.016_bib43","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1021\/acs.jcim.0c00971","article-title":"OpenChem: A deep learning toolkit for computational chemistry and drug design","volume":"61","author":"Korshunova","year":"2021","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-019-02613-4","article-title":"Toxicity testing in the 21st century: Progress in the past decade and future perspectives","volume":"94","author":"Krewski","year":"2020","journal-title":"Archives of Toxicology"},{"key":"10.1016\/bs.apha.2025.01.016_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2024.2314257","article-title":"EIF4A3 targeted therapeutic intervention in glioblastoma multiforme using phytochemicals from Indian medicinal plants\u2013an integration of phytotherapy into precision onco-medicine","author":"Kulavi","year":"2024","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.1016\/bs.apha.2025.01.016_bib47","doi-asserted-by":"crossref","unstructured":"Kulavi, S., Banerjee, S., Sengupta, T., Ghosh, C., Saha, M., & Chatterjee, S. (2021). Virtual screening through molecular docking analysis to identify potential natural inhibitor (s) of Lyn tyrosine kinase-an in-silico approach.","DOI":"10.9734\/jpri\/2021\/v33i50A33385"},{"key":"10.1016\/bs.apha.2025.01.016_bib48","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.psep.2024.06.024","article-title":"Advancing sustainable biofuel production: A computational insight into microbial systems for isopropanol synthesis and beyond","volume":"188","author":"Kumar","year":"2024","journal-title":"Process Safety and Environmental Protection: Transactions of the Institution of Chemical Engineers, Part B"},{"key":"10.1016\/bs.apha.2025.01.016_bib49","series-title":"ACS Symposium Series","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/bk-2014-1164.ch008","article-title":"The making of reaxys\u2014Towards unobstructed access to relevant chemistry information","author":"Lawson","year":"2014"},{"issue":"7553","key":"10.1016\/bs.apha.2025.01.016_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.apha.2025.01.016_bib51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.apha.2025.01.016_bib52","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine learning in chemoinformatics and drug discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug Discovery Today"},{"issue":"9","key":"10.1016\/bs.apha.2025.01.016_bib53","article-title":"Artificial intelligence in drug discovery: Recent advances and future perspectives","volume":"16","author":"Luna","year":"2021","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/17460441.2022.1985108","article-title":"Success stories of AI in drug discovery - where do things stand?","volume":"17","author":"Mak","year":"2022","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib55","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: Present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.016_bib56","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Research"},{"issue":"3s","key":"10.1016\/bs.apha.2025.01.016_bib57","doi-asserted-by":"crossref","first-page":"s387","DOI":"10.5530\/ijper.56.3s.146","article-title":"Impact of artificial intelligence (AI) on drug discovery and product development","volume":"56","author":"Narayanan","year":"2022","journal-title":"Indian Journal of Pharmaceutical Education"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib58","first-page":"45","article-title":"Review on cambridgesoft chembiodraw ultra 13.0 v","volume":"5","author":"Narayanaswamy","year":"2013","journal-title":"International Journal of Theoretical and Applied Sciences"},{"key":"10.1016\/bs.apha.2025.01.016_bib59","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2147\/DDDT.S424991","article-title":"The coming of age of AI\/ML in drug discovery, development, clinical testing, and manufacturing: The FDA perspectives","volume":"17","author":"Niazi","year":"2023","journal-title":"Drug Design. Development and Therapy"},{"key":"10.1016\/bs.apha.2025.01.016_bib60","doi-asserted-by":"crossref","DOI":"10.2174\/0115748871310261240929163138","article-title":"Navigating dry eye research: A comprehensive review of etiology, clinical trials, patents, and recent advancements","author":"Pal","year":"2024","journal-title":"Reviews on Recent Clinical Trials"},{"issue":"17","key":"10.1016\/bs.apha.2025.01.016_bib61","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.bmcl.2018.06.046","article-title":"Recent applications of machine learning in medicinal chemistry","volume":"28","author":"Panteleev","year":"2018","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib62","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.imed.2021.10.001","article-title":"Artificial intelligence and machine learning in drug discovery and development","volume":"2","author":"Patel","year":"2022","journal-title":"Intelligent Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2025.01.016_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: The pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"11","key":"10.1016\/bs.apha.2025.01.016_bib64","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/ed100697w","article-title":"ChemSpider: An online chemical information resource","volume":"87","author":"Pence","year":"2010","journal-title":"Journal of Chemical Education"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/ETLS20210246","article-title":"Artificial intelligence, machine learning, and deep learning for clinical outcome prediction","volume":"5","author":"Pettit","year":"2021","journal-title":"Emerging Topics in Life Sciences"},{"issue":"25","key":"10.1016\/bs.apha.2025.01.016_bib66","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.2174\/092986709788803286","article-title":"Receptor dependent multidimensional QSAR for modeling drug-receptor interactions","volume":"16","author":"Polanski","year":"2009","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2025.01.016_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DDDT.S2352","article-title":"Beyond post-marketing research and MedWatch: Long-term studies of drug risks","volume":"2007","author":"Resnik","year":"2007","journal-title":"Drug Design Development and Therapy"},{"issue":"0","key":"10.1016\/bs.apha.2025.01.016_bib68","doi-asserted-by":"crossref","first-page":"baq020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: The human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database: The Journal of Biological Databases and Curation"},{"key":"10.1016\/bs.apha.2025.01.016_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-030-16391-4_11","article-title":"Artificial Intelligence and personalized medicine","volume":"178","author":"Schork","year":"2019","journal-title":"Cancer Treatment and Research"},{"key":"10.1016\/bs.apha.2025.01.016_bib70","first-page":"66","article-title":"Mycin: A knowledge-based computer program applied to infectious diseases","volume":"1977","author":"Shortliffe","year":"1977","journal-title":"Proceedings of the Annual Symposium on Computer Application in Medical Care"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib71","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacological Reviews"},{"issue":"9","key":"10.1016\/bs.apha.2025.01.016_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012417","article-title":"An exploration into CTEPH medications: Combining natural language processing, embedding learning, in vitro models, and real-world evidence for drug repurposing","volume":"20","author":"Steiert","year":"2024","journal-title":"PLoS Computational Biology"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.016_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1109\/MSPEC.2019.8678513","article-title":"IBM Watson, heal thyself: How IBM overpromised and underdelivered on AI health care","volume":"56","author":"Strickland","year":"2019","journal-title":"IEEE Spectrum"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/2229-3485.71852","article-title":"Phase IV of drug development","volume":"1","author":"Suvarna","year":"2010","journal-title":"Perspectives in Clinical Research"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.016_bib75","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.54097\/fcis.v3i2.7575","article-title":"Deep learning in drug discovery: Applications and limitations","volume":"3","author":"Tang","year":"2023","journal-title":"Frontiers in Computing and Intelligent Systems"},{"issue":"1","key":"10.1016\/bs.apha.2025.01.016_bib77","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/genedge.5.1.132","article-title":"AI-based drug discovery company atomwise sets its sights on inflammatory disease market","volume":"5","author":"Thomas","year":"2023","journal-title":"GEN Edge"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14573\/altex.1803011","article-title":"The US federal Tox21 program: A strategic and operational plan for continued leadership","volume":"35","author":"Thomas","year":"2018","journal-title":"ALTEX: Alternativen zu Tierexperimenten"},{"key":"10.1016\/bs.apha.2025.01.016_bib79","doi-asserted-by":"crossref","DOI":"10.47488\/dhrp.v3iS1.95","article-title":"AI-powered precision oncology: Computational insights redefining therapeutic landscapes","author":"Tippur","year":"2023","journal-title":"DHR Proceedings"},{"issue":"6\u20137","key":"10.1016\/bs.apha.2025.01.016_bib80","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Molecular Informatics"},{"issue":"7873","key":"10.1016\/bs.apha.2025.01.016_bib81","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.apha.2025.01.016_bib82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib83","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/life14020233","article-title":"Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery","volume":"14","author":"Visan","year":"2024","journal-title":"Life"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib84","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/ci025620t","article-title":"Active learning with support vector machines in the drug discovery process","volume":"43","author":"Warmuth","year":"2003","journal-title":"Journal of Chemical Information and Computer Sciences"},{"issue":"4","key":"10.1016\/bs.apha.2025.01.016_bib85","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-4571(199704)48:4<349::AID-ASI8>3.0.CO;2-W","article-title":"Chemical abstracts service chemical registry system: History, scope, and impacts","volume":"48","author":"Weisgerber","year":"1997","journal-title":"Journal of the American Society for Information Science"},{"key":"10.1016\/bs.apha.2025.01.016_bib86","series-title":"ACS Symposium Series","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/bk-2010-1060.ch002","article-title":"ChemSpider: Integrating structure-based resources distributed across the internet","author":"Williams","year":"2010"},{"issue":"2","key":"10.1016\/bs.apha.2025.01.016_bib87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1109\/TNNLS.2015.2513006","article-title":"A novel twin support-vector machine with pinball loss","volume":"28","author":"Xu","year":"2017","journal-title":"IEEE Transactions on Neural Networks and Learning Systems"},{"issue":"D1","key":"10.1016\/bs.apha.2025.01.016_bib88","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: A drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Research"}],"container-title":["Advances in Pharmacology","Revolutionizing Drug Discovery:Cutting-Edge Computational Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105435892500016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105435892500016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T19:10:35Z","timestamp":1743621035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105435892500016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443346491"],"references-count":88,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2025.01.016","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}